mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
0.9 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.1 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.004 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |